Özkurt, E. Et Al. 2022. Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes. BREAST CARE , vol.17, no.6 , 554-560.

Özkurt, E., Emiroğlu, S., Cabioğlu, N., Karanlık, H., Önder, S., Tükenmez, M., ... İğci, A.(2022). Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes. BREAST CARE , vol.17, no.6, 554-560.

Özkurt, Enver Et Al. "Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes," BREAST CARE , vol.17, no.6, 554-560, 2022

Özkurt, Enver Et Al. "Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes." BREAST CARE , vol.17, no.6, pp.554-560, 2022

Özkurt, E. Et Al. (2022) . "Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes." BREAST CARE , vol.17, no.6, pp.554-560.

@article{article, author={Enver Özkurt Et Al. }, title={Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes}, journal={BREAST CARE}, year=2022, pages={554-560} }